JP2024517971A5 - - Google Patents

Info

Publication number
JP2024517971A5
JP2024517971A5 JP2023570394A JP2023570394A JP2024517971A5 JP 2024517971 A5 JP2024517971 A5 JP 2024517971A5 JP 2023570394 A JP2023570394 A JP 2023570394A JP 2023570394 A JP2023570394 A JP 2023570394A JP 2024517971 A5 JP2024517971 A5 JP 2024517971A5
Authority
JP
Japan
Prior art keywords
acid
group
compound
unit
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023570394A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517971A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/062985 external-priority patent/WO2022238553A1/en
Publication of JP2024517971A publication Critical patent/JP2024517971A/ja
Publication of JP2024517971A5 publication Critical patent/JP2024517971A5/ja
Pending legal-status Critical Current

Links

JP2023570394A 2021-05-14 2022-05-12 放射性医薬品のソマトスタチン受容体リガンドおよびその前駆体 Pending JP2024517971A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21173849 2021-05-14
EP21173849.7 2021-05-14
PCT/EP2022/062985 WO2022238553A1 (en) 2021-05-14 2022-05-12 Radiopharmaceutical somatostatin receptor ligands and precursors thereof

Publications (2)

Publication Number Publication Date
JP2024517971A JP2024517971A (ja) 2024-04-23
JP2024517971A5 true JP2024517971A5 (enExample) 2025-04-15

Family

ID=75936725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023570394A Pending JP2024517971A (ja) 2021-05-14 2022-05-12 放射性医薬品のソマトスタチン受容体リガンドおよびその前駆体

Country Status (11)

Country Link
US (1) US20240317780A1 (enExample)
EP (1) EP4337270A1 (enExample)
JP (1) JP2024517971A (enExample)
KR (1) KR20240008341A (enExample)
CN (1) CN117320759A (enExample)
AU (1) AU2022273184A1 (enExample)
BR (1) BR112023023890A2 (enExample)
CA (1) CA3214915A1 (enExample)
IL (1) IL308414A (enExample)
MX (1) MX2023013485A (enExample)
WO (1) WO2022238553A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117777296B (zh) * 2024-02-28 2024-05-28 北京肿瘤医院(北京大学肿瘤医院) B7h3亲和体及其诊疗核素标记物的制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE070098T2 (hu) * 2017-07-28 2025-05-28 Univ Muenchen Tech Kettõs módusú radioaktív jelzõ és terapeutikumok

Similar Documents

Publication Publication Date Title
JP2020528461A5 (enExample)
JP2024522200A5 (enExample)
AU2025204473A1 (en) Marking Precursor with Squaric Acid Coupling
JP3553940B2 (ja) コントラスト剤として使用するためのトリシクロポリアザマクロシクロホスホン酸、それらの錯体および誘導体
JP2024517971A5 (enExample)
RU2011116223A (ru) Селективные ингибиторы сепразы
RU2017114360A (ru) Радиофармацевтический конъюгат
JP2024529307A5 (enExample)
BRPI0718700B1 (pt) Heterodímeros de ácido glutâmico e kit
JP2022509220A5 (ja) 腫瘍抗原標的化剤、医薬組成物、癌診断薬又は癌治療薬、ｉｎ ｖｉｔｒｏ法、及びその化合物
US20240100201A1 (en) Labeling precursors and radiotracers for nuclear medicine diagnosis and therapy of prostate cancer-induced bone metastases
JP2024505374A (ja) デュアルモード放射性トレーサーおよびその療法
JP2018524352A (ja) Ｈｂｅｄ−ビスホスホネート、その放射性金属コンジュゲート、およびセラノスティック剤としてのそれらの使用
WO2011021390A1 (ja) ビスホスホン酸誘導体及びその放射性金属核種標識体
CN115484992B (zh) 药物制剂
ES2899033T3 (es) Agentes de contraste diméricos
KR20240158290A (ko) 핵의학에서 사용되는 테라노스틱스를 위한 3개 이상의 표적화 벡터를 갖는 전구체 표지자 및 방사성 추적자
JP2022518598A5 (enExample)
CA2514885A1 (en) Diagnostic imaging agents with mmp inhibitory activity
JP2010502585A5 (enExample)
IL305134A (en) Dual mode radio and medical tracker
JP2010540627A5 (enExample)
CN113747927A (zh) 包含淀粉酶可切割接头的前列腺特异性膜抗原(psma)配体
EP1061956B1 (en) Manganese chelates with high relaxivity in serum
NZ792994B2 (en) Psma combiner and use thereof